Prostate Cancer in the Transgender Community

Photo Credit: Franziska Neumeister https://www.flickr.com/photos/127085184@N05/This section of our website has been designed to provide information about prostate cancer for male-to-female (MTF) individuals and their health care providers. For clarity we will refer to these individuals as transgender women, or trans women, but recognize that many individuals identify along a spectrum and may not choose to identify in this manner.
  • Transgender women have a prostate and it is possible for them to develop prostate cancer, regardless of whether or not they have undergone gender-confirming surgery.
  • The decision to screen for prostate cancer, and how to do so, should be made by the patient in the context of a dedicated care-discussion with their healthcare provider including risk factors, such as having a family history of prostate cancer or being of African or Caribbean decent, and taking into account the fact that prostate cancer screening may be considered not gender affirming for some transgender women, and may be both physically and emotionally painful.
  • There are limited reports of prostate cancer in trans women and Prostate Cancer Canada encourages more research in this area to gain a better understanding of population level risk and the personal experience of trans women undergoing testing, diagnosis and treatment of prostate cancer.
 

Why is it
important?

Should I
get tested?

Resources

For trans women experiencing prostate cancer, Prostate Cancer UK is trialling an online community support group. More information can be found here.
 
Definitions are adapted from: Provincial Health Services Authority (PHSA), Transgender Health Information Program, Glossary. Available here.

QMUNITY, Queer Terminology from A to Q. Available here.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive